Refine by
-
Letter to FDA on Medication Access
Letter requesting information from the FDA so stakeholders can assist in gathering available data on clozapine prior to the next meeting of the Drug Safety and Risk Management Advisory Committee and the Psychopharmacologic Drugs Advisory Committee. -
Letter to HHS and Departments of Labor and Treasury on Parity
Letter urging the Departments of Health and Human Services, Labor, and the Treasury to finalize the proposed rules to strengthen the Mental Health Parity and Addiction Equity Act (Parity Act) of 2008, which will make a significant difference in improving access to the substance use disorder and mental health treatment that people need and deserve. -
Amicus Brief on Health Coverage and Health Equity
Amicus brief filed for C.P. v. Blue Cross Blue Shield of Illinois, emphasizing that Third Party Administrators must not be allowed to contract around their legal obligation not to discriminate under Section 1557 of the Affordable Care Act. -
Letter to Biden Administration on Mental Health Funding and Social Supports
Letter requesting the Biden Administration maximize existing caregiver resources and programs within the federal government with the creation of an Office of Caregiver Health. -
Letter to Congressional Committee Leadership on Medicare and Telehealth
Letter to the House Energy and Commerce Committee leadership to urge a full committee mark up in support of the two-year delay of the six-month in-person requirement to access telemental health services under Medicare. -
Letter to Congressional Committee Leadership on Child and Adolescent Mental Health
Letter of support to Appropriations Committee leadership for increased STOP School Violence Act funding in FY 25 to bring evidence-based safety programs and strategies to schools on topics including suicide, bullying, and violence prevention. -
Statement on Medication Access and Health Equity
Press release applauding the Supreme Court’s unanimous ruling reversing the Fifth Circuit’s decision in Alliance for Hippocratic Medicine et al. v FDA et al, expressing support of the FDA’s role in safeguarding patients, and urging the Department of Justice to continue rigorously defending that authority. -
Letter to Congressional Bill Sponsor on Mental Health Workforce
Letter expressing support for the Community Mental Wellness Worker Act, which would authorize a new $25 million SAMHSA program to help community mental health clinics train a corps of community mental wellness workers capable of providing short term counseling and interviewing interventions to people with depression, anxiety and substance use disorders in their community. -
Letter to Congressional Bill Sponsors on Child and Adolescent Mental Health
Letter to Congressional bill sponsors of the Kids Online Safety Act (H.R. 7891/S. 1409), expressing strong support for this bipartisan, bicameral act that would hold social media companies accountable after their repeated failures to protect children and adolescents from the practices that make their platforms more harmful. -
Regulatory Comment to HUD on Criminal Justice, Health Equity and Social Supports
Regulatory comment addressed to Acting HUD Secretary Todman in support of the HUD’s efforts to decrease barriers to HUD housing programs for formerly incarcerated and convicted people as exemplified in the proposed rule, “Reducing Barriers to HUD-Assisted Housing” (FR-6362-P-01).
